Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T05:46:21.681Z Has data issue: false hasContentIssue false

Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury

Published online by Cambridge University Press:  11 March 2014

Matteo Pardini
Affiliation:
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, ItalyMagnetic Resonance Research Centre on Nervous System Diseases, University of Genoa, Genoa, Italy
Frank Krueger
Affiliation:
Molecular Neuroscience Department, George Mason University, Fairfax, Virginia, USADepartment of Psychology, George Mason University, Fairfax, Virginia, USA
Colin A. Hodgkinson
Affiliation:
Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA
Vanessa Raymont
Affiliation:
Department of Medicine, Imperial College London, London, UK
Maren Strenziok
Affiliation:
Department of Psychology, George Mason University, Fairfax, Virginia, USA
Mario Amore
Affiliation:
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy
Eric M. Wassermann
Affiliation:
Behavioral Neurology Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
David Goldman
Affiliation:
Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA
Jordan H. Grafman*
Affiliation:
Rehabilitation Institute of Chicago, Chicago, Illinois, USA
*
*Address for correspondence: Jordan Grafman, PhD, Director, Brain Injury Research, Coleman Chair in Physical Medicine and Rehabilitation, Rehabilitation Institute of Chicago, 345 East Superior Street, Chicago, IL 60611, USA. (Email: jgrafman@northwestern.edu)
Rights & Permissions [Opens in a new window]

Abstract

Objective

This study evaluated whether structural brain lesions modulate the relationship between pathological aggression and the dopaminergic system in traumatic brain injury (TBI). While converging evidence suggests that different areas of the prefrontal cortex modulate dopaminergic activity, to date no evidence exists of a modulation of endogenous dopaminergic tone by lesion localization in penetrating TBI (pTBI).

Methods

This study included 141 male Caucasian veterans who suffered penetrating pTBI during their service in Vietnam and 29 healthy male Caucasian Vietnam veterans. Participants were genotyped for 3 functional single nucleotide polymorphisms (SNPs): dopamine receptor D1 (DRD1) rs686, dopamine receptor D2 (DRD2) rs4648317, and catechol-O-methyltransferase (COMT) Val158Met. Patients underwent brain CT scans and were divided into medial prefrontal cortex, lateral prefrontal cortex, and posterior cortex lesion groups. Long-term aggression levels were evaluated with the agitation/aggression subscale of the Neuropsychiatric Inventory.

Results

Our data showed that carriers of more transcriptionally active DRD1 alleles compared to noncarriers demonstrated greater aggression levels due to medial prefrontal cortex lesions but reduced aggression levels due to lateral prefrontal cortex lesions independently of DRD2 rs4648317 or COMT Val158Met genotypes.

Conclusions

Our results suggest that the relationship between pTBI-related aggression and the dopaminergic system is modulated by lesion location. Potentially lesion location could represent an easy-to-use, widely available, para-clinical marker to help in the development of an individualized therapeutic approach to pTBI-related pathological aggression.

Information

Type
Original Research
Copyright
Copyright © Cambridge University Press 2014 
Figure 0

Figure 1Subtraction lesions maps for the mPFC group (red), lPFC group (green), and non-PFC group (blue). For each group, the subtraction lesion map shows those brain areas that were more lesioned in 1 group compared to the other groups. Note that each subject was only included in 1 group.

Figure 1

Table 1Demographic and clinical data for the experimental DRD1 rs686 groups

Figure 2

Figure 2NPI-a scores (mean ± s.e.m.) for the lesion groups divided according to the functional SNP DRD1 rs686. *Indicates a significant difference between the 2 genotype groups at p < 0.05 (Bonferroni correction).